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AIMS: To determine the level of serum procalcitonin
and cerebrospinal fluid cytokines in children with
bacterial or viral meningitis and to document the use
of these parameters in differential diagnosis.
Results: Before the start of antibiotic treatment,
serum procalcitonin and tumor necrosis factor alpha
levels were found to be higher in acute bacterial
meningitis compared with viral meningitis and with
the control group. Similarly, cerebrospinal fluid
interleukin-6 levels were found to be significantly
higher in children with acute bacterial meningitis
compared with viral meningitis. However, no signifi-
cant difference was determined between groups in
respect to the cerebrospinal fluid interleukin-8 level.
Conclusion: Serum procalcitonin and cerebrospinal
fluid tumor necrosis factor alpha levels can be used
in the early diagnosis of bacterial meningitis. Simi-
larly, they may be useful adjuncts in differential
diagnosis of bacterial and viral meningitis.
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Introduction
Despite the advances in diagnosis and treatment of
infectious diseases, meningitis and encephalitis are
still considered to be important causes of mortality
and morbidity.
1 In efforts to decrease the morbidity
and mortality related to bacterial meningitis, having
an early diagnosis and starting immediate empirical
therapy are the key factors. In the early phases of
acute bacterial and viral meningitis, signs and symp-
toms are often non-specific and it is not always
possible to make a differential diagnosis on the basis
of routine examination of cerebrospinal fluid (CSF).
In untreated bacterial meningitis, Gram staining of
CSF reveals bacteria in about 50/80% of cases and
cultures are positive in at least 85% of cases.
However, sensitivity of both tests is less than 50% in
patients who are already on antibiotic treatment.
2,3
Waiting for at least 2 days was recommended to
identify bacterial growth in CSF cultures, whereas this
period is 3/8 days for viral cultures.
4,5 Moreover,
identifying the frequently encountered viral agents
via polymerase chain reaction is not always possible
in every institution.
6 Therefore, intensive research
has been carried out to find new and rapid diagnostic
methods for differential diagnosis of bacterial and
viral meningitis.
Procalcitonin (PCT), which is a calcitonin propep-
tide, is supposed to be synthesized in C cells of the
thyroid gland
7 and secreted from leukocytes of the
peripheral blood. The secretion of PCT was found to
increase in the presence of bacterial lipopolysacchar-
ides and cytokines that are associated with sepsis.
8,9
It was previously shown that serum PCT levels
increase during the course of bacterial, parasitic or
fungal infections, but remain normal or slightly
increase in viral infections and inflammatory reac-
tions that are not infectious.
10,11
Cytokines are hormone-like proteins and function
by binding to their specific receptors.
12 There is
emerging evidence that the level of tumor necrosis
factor alpha (TNF-a), interleukin (IL)-6 and IL-8 may
play important roles in pathogenesis of meningitis,
and are successfully used in early diagnosis as well as
differential diagnosis of bacterial and viral
meningitis.
1316
The aim of the present study was to determine the
role of serum PCT and CSF IL-6, IL-8 and TNF-a levels
in early diagnosis of bacterial meningitis and to
document their efficacy in differential diagnosis of
viral and bacterial meningitis
Materials and methods
A total of 44 children with meningitis admitted to a
University Hospital were followed in this prospective
study. The mean age was 60.19 /31.3 months and the
age range was 4/160 months. Twenty-two children
were diagnosed as bacterial meningitis and the other
22 children as viral meningitis. The control group was
revealed by 10 children whose age range was
between 6 and 132 months.
Informed signed consent was obtained from par-
ents for their children to participate in the study, and
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Meningitis was diagnosed according to evaluation
of history, physical examination, CSF laboratory
findings, identification of bacterial agents in CSF
Gram staining and cultures. Meningitis is defined as
bacterial if the CSF laboratory findings (increased
protein   /2 g/l, decreased glucose ratio B /0.4, and
leukocyte count   /1500 /10
6/l and polymorph nu-
clear leukocyte domination), identification of bacter-
ial agents in Gram staining and/or bacterial culture
were positive; or was defined as viral if the viral
culture, serological testing, pleocytosis, or reverse
transcriptase polymerase chain reaction were positive
and the bacterial culture was negative.
The control group was defined by an absence of
inflammatory cells in CSF (cell count B /5 /10
6/l and
sterile for bacteriologic and virologic findings) on
afebrile and meningeal sign-positive children. Eight
children were diagnosed with epilepsy and two with
relapse-free acute lymphoblastic leukemia.
Blood serum samples were taken from all cases at
the time of diagnosis and at 48/72 h of treatment.
The blood glucose level, peripheral leukocyte count,
erythrocyte sedimentation rate and serum PCT in
blood serum samples and the protein, glucose,
number and type of cells, TNF-a, IL-6 and IL-8 levels
in CSF samples were simultaneously investigated.
These parameters were investigated only once at the
time of diagnosis in the control group. Symptoms and
findings at the time of diagnosis, demographical
data, peripheral leukocyte count, erythrocyte sedi-
mentation rate, and follow-up body temperature
(body temperature   /37.88C, armpit) of cases were
monitored.
Collected serum and CSF samples were centrifuged
at 2000 rotation for 15 min and stored at  /808C until
the analysis of cytokines. Cerebrospinal fluid IL-6,
IL-8 and TNF-a levels were measured using commer-
cial enzyme ‘immunoassay’ kits (ACCUCYTE human
TNF alpha ELISA, ACCUCYTE human IL-6 ELISA
and ACCUCYTE human IL-8 ELISA; Cytimmune
Science Inc., Rockville, MD, USA). Serum PCT levels
were studied by the immunoluminometric method in
Analyzer luminometer equipment using the Lumitest
kit (Lumitest PCT kits BRAHMS Diagnostica, Berlin,
Germany).
Statistical analysis of data was carried out in a
Windows setting using the SPSS 10.0 program.
Differences between groups in continuous variables
were tested for significance with the Mann/Whitney
test. Differences in frequencies of findings between
groups were analyzed by Fischer’s exact test. The
Spearman correlation coefficient (r) was used to
evaluate the relation between specific variables.
Two-tailed p5 /0.05 was considered significant.
Results
Of the 44 cases with meningitis, 29 (65.9%) were
males and 15 (34.1%) were females. The mean age of
the patients was (9 /standard deviation) 65.299 /51.91
months (Table 1). There was no difference between
bacterial and viral meningitis groups in respect to
mean age (p  /0.05). Clinical characteristics and
laboratory findings in both groups are summarized
in Table 1. The most common symptoms at the time
of diagnosis in all study groups were fever (100%),
nausea or vomiting (40.9%) and convulsion (31.8%).
CSF findings of patients with bacterial and viral
meningitis, and of the control group, are presented in
Table 2. Bacterial culture revealed Neisseria menin-
gitidis in eight cases, Streptococcus pneumoniae in
eight cases, Haemophilus influenzae in four cases,
Escherichia coli in one case, and Pseudomonas
aeuroginosae in one case. Six patients had viral
meningitis while experiencing an episode of mumps,
two developed the diseases simultaneously with
measles, and two showed viral meningitis during an
episode of varicella, which were all verified by CSF
serology. Additionally, reverse transcriptase polymer-
ase chain reaction using the previously defined
primers detected the presence of RNA of entero-
viruses in CSF for 12 patients.
Serum PCT and CSF cytokine levels in all groups
are summarized in Table 3. At the time of diagnosis,
patients with bacterial meningitis had increased
serum PCT, CSF IL-6, IL-8 and TNF-a levels compared
with the control group (pB /0.001). A similar compar-
ison between bacterial and viral meningitis at the
time of diagnosis also revealed increased serum PCT
and CSF cytokines levels in bacterial meningitis
patients (PCT, pB /0.001; CSF IL-6, pB /0.05; and
TNF-a, pB /0.001). No significant difference was
determined between bacterial and viral meningitis
groups in respect to the CSF IL-8 level. Similarly,
there was no significant difference between viral
meningitis and control groups when serum PCT and
CSF TNF-a levels were compared (p  /0.05). IL-6 and
IL-8 levels in CSF were significantly higher in viral
meningitis groups compared with the control group
(pB /0.01). However, the assessment of the same
parameters at 48/72 h after the start of treatment
showed also significantly higher levels of serum PCT
and CSF TNF-a, IL-6 (pB /0.001) and IL-8 (pB /0.01) in
the bacterial meningitis group than in the viral
meningitis group. At 48/72 h after the start of
treatment the decrease of serum PCT and CSF TNF-
a, IL-6 and IL-8 levels of the bacterial meningitis
group was statistically significant compared with
levels at the start of treatment (pB /0.001).
A strong correlation between IL-6 and IL-8 in the
bacterial meningitis group was evaluated (r /0.957,
p /0.001). There was no correlation among other
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PCT and CSF cytokines in the viral meningitis group
and the control group.
Discussion
Previous studies have revealed that in most children
and adults the serum PCT level is increased in acute
bacterial meningitis cases, but remains normal in viral
meningitis.
17,18 Thus it was concluded that the best
diagnostic parameter in differential diagnosis of
bacterial and viral meningitis in children is serum
PCT, whereas the PCT increase in the CSF was
considered non-specific and can only be used in
the follow-up of the disease. Since PCT decreases
with successful treatment and becomes unidentifi-
able, it may be helpful in follow-up.
1720
In the present study, a significant increase was
found in the serum PCT of bacterial meningitis cases
at the time of diagnosis in comparison with the
control group. However, there was no such increase
in the viral meningitis group. Procalcitonin levels
measured at 48/72 h of the treatment were found to
be less than the level measured at the beginning of
treatment, but did not return to normal values as in
the control group. This finding suggests that the
serum PCT level continues to be high for 48/72 h
(despite treatment) and can be used for diagnosis for
at least 48 h. Nevertheless, it is more reliable in
diagnosis when measured before starting any treat-
ment. Normally, PCT is very low in circulation or in
serum of healthy subjects as well as in patients with
inflammatory diseases, reaches high concentrations
in patients with severe bacterial infection and de-
creases rapidly after appropriate antibiotic therapy.
21







Female 9 (40.9) 6 (27.3) 4 (40.0)
Male 13 (59.1) 16 (72.7) 6 (60.0)
Age (months) 56.69 /25.5 74.39 /30.3 60.19 /27.6
Clinical findings
Fever 22 (100.0) 22 (100.0) 0 (0.0)
Nausea or vomiting 6 (27.2) 12 (54.5) 1 (10.0)
Headhache 11 (50.0) 6 (27.2) 1 (10.0)
Convulsion 7 (31.8) 7 (31.8) 9 (90.0)
Parotitis 0 (0.0) 6 (27.2) 0 (0.0)
Laboratory findings
Erytrocyte sedimentation rate (mm/h) 30.99 /29.5 18.99 /12.5 18.09 /8.0
Leukocyte count (/mm
3) 16.289 /9.67 /10
9 8.999 /5.92 /10
9 5.639 /1.41 /10
9
Numbers in parantheses are percentages.
Table 2. Laboratory ﬁndings of all groups

















6 2839 /80 /10
6 1749 /130 /10
6 759 /56 /10
6 0.09 /0.0 /10
6 pB /0.01, a and b,
a and c, b and d
pB /0.001, a and e





0.799 /0.30 0.839 /0.18 0.189 /0.12 0.079 /0.01 0.009 /0.00 pB /0.01, a and c,
b and d
pB /0.001, a and e
CSF protein (mg/l) 2.049 /1.33 1.099 /0.68 0.519 /0.20 0.549 /0.24 0.289 /0.11 pB /0.01, a and c,
a and b
pB /0.001, a and e
pB /0.05, b and d,
c and e
CSF glucose (mmol/l) 1.719 /1.22 2.369 /0.67 3.199 /0.93 3.119 /0.93 4.189 /0.69 pB /0.01, a and c,
c and e
pB /0.05, a and b,
a and e
Data presented as mean9 /standard deviation.
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acute bacterial meningitis, but generally normal in
viral meningitis.
1416,22 We observed similar findings
in our study. Previous studies revealed that the CSF
TNF-a concentration increased in experimental bac-
terial meningitis models; however, it remained at very
low levels in the blood.
13 However, in several clinical
studies, TNF-a is high increased in the serum of
patients with bacterial meningitis.
13,22,23
In our study, the CSF TNF-a level was also higher
in acute bacterial meningitis cases than those in viral
meningitis and the control group. Although the TNF-
a level decreased at 48/72 h, they were still higher
than those in the viral meningitis and control groups.
None of the viral meningitis cases showed an
increase in the TNF-a level and the difference was
non-significant compared with the control group.
These findings suggest that TNF-a can be used to
differentiate bacterial and viral meningitis. Although
TNF-a is considered a sensitive and reliable marker in
diagnosis of bacterial meningitis, it is not as much
practical as serum PCT in the diagnosis. This is
because measurement of CSF TNF-a is much more
invasive, which requires lumbar punction. Addition-
ally, PCT is stable at room temperature, can be
observed regularly in blood samples and can be
measured together with routine variables. Serum PCT
results can be obtained in 2 h and can be conducted
with only 20 ml of serum. We observed a gradual
decrease in TNF-a levels after antibiotic treatment,
and this shows that TNF-a can be used to follow the
progression of disease and to monitor the effect of
antibiotics on outcome of meningitis. However,
further research is needed to determine the exact
role of TNF-a measurements in bacterial meningitis.
Cerebrospinal fluid IL-8 measurement was in-
creased in patients with both bacterial meningitis
and viral meningitis. However, it is not useful in
differential diagnosis of bacterial and viral meningitis.
Although some authors reported that neither IL-8 nor
TNF-a and any other CSF parameter can be used in
differential diagnosis of meningitis,
2426 Azuma et al.
found increased CSF TNF-a only in bacterial menin-
gitis cases. Thus, they believe that the CSF cytokine
level could be used as a means of rapid diagnosis.
27
Our findings suggested that serum PCT and CSF
cytokines (IL-6, IL-8 and TNF-a) can be used in
diagnosis of meningitis; moreover, serum PCT and
CSF IL-6 and TNF-a can be measured to differentiate
bacterial meningitis from viral meningitis.
Mastrioanni et al.
28 found that the IL-8 level was
high both in tuberculosis meningitis patients and in
patients with bacterial meningitis. However, IL-8
remained high for months in tuberculosis meningitis
as opposed to bacterial meningitis.
29 Seki et al.
30
found high levels of CSF IL-8 in bacterial meningitis
cases and showed that CSF IL-8 levels were much
lower in viral meningitis patients. In several studies it
was also shown that the CSF IL-8 level increased in
viral meningitis cases, although the increase was not
as much as that in bacterial meningitis. Nevertheless,
the CSF IL-8 level could be used in meningitis
diagnosis.
2931
In this study, IL-8 levels at the time of diagnosis of
meningitis were highest in the bacterial meningitis
group. It was also increased in the viral meningitis
group when compared with the control group. No
statistically significant difference was found between
bacterial and viral meningitis groups in terms of the
CSF IL-8 level at the time of diagnosis and 48/72 h.
Our findings revealed that the CSF IL-8 level can be
useful in diagnosis of meningitis; however, it was not
a useful marker in distinguishing between bacterial
and viral meningitis.
In conclusion, this is the first study using a
repertoire of cytokines and PCT in human serum
and CSF to diagnose meningitis and to determine
their roles in differential diagnosis of viral and
bacterial meningitis. In the presence of meningeal
symptoms, measurements of PCT in the serum and
TNF-a and IL-6 in the CSF could be an early and
important diagnostic marker used in differential
diagnosis of bacterial and viral meningitis as well as
other diseases causing meningeal irritation. Serum
Table 3. Serum PCT and CSF cytokines values of all group














PCT (ng/l) 75.89 /29.8 35.79 /19.6 0.39 /0.2 0.39 /0.1 0.39 /0.2 pB /0.001, a and b, a and c,
a and e, b and d
IL-6 (pg/ml) 349.39 /169.2 234.09 /195.0 168.19 /143.8 108.09 /75.2 17.59 /5.4 pB /0.001, a and b, a and e,
b and d, c and d
pB /0.01, c and e
pB /0.05, a and c
IL-8 (pg/ml) 194.49 /98.7 154.19 /146.1 152.99 /75.3 109.09 /53.3 128.59 /20.8 pB /0.001, a and e, c and d,
c and e
pB /0.01, a and b, b and d
TNF-a (pg/ml) 26.59 /22.6 12.49 /10.2 1.69 /0.3 1.79 /0.6 1.79 /0.5 pB /0.001, a and b, a and c,
a and e, b and d
Data presented as mean9 /standard deviation.
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intervention such as lumbar puncture and, with its
stable molecular structure in serum, it can be
frequently measured in serum for the diagnosis and
follow-up of bacterial meningitis, making this para-
meter more useful than TNF-a and IL-6 in clinical
practice.
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